<SEC-DOCUMENT>0001628280-24-036131.txt : 20240808
<SEC-HEADER>0001628280-24-036131.hdr.sgml : 20240808
<ACCEPTANCE-DATETIME>20240808160908
ACCESSION NUMBER:		0001628280-24-036131
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240808
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240808
DATE AS OF CHANGE:		20240808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cibus, Inc.
		CENTRAL INDEX KEY:			0001705843
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				271967997
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38161
		FILM NUMBER:		241188333

	BUSINESS ADDRESS:	
		STREET 1:		6455 NANCY RIDGE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 450-0008

	MAIL ADDRESS:	
		STREET 1:		6455 NANCY RIDGE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Calyxt, Inc.
		DATE OF NAME CHANGE:	20170504
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cbus-20240808.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:89c236c4-fbb5-4d54-a6ca-42af59849496,g:42efc36a-8851-4202-b0b1-6d8ca1098511,d:a7787eb267a142a9a329da33f1e3e934-->
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cbus-20240808</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001705843</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cbus-20240808.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001705843</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-08</xbrli:startDate><xbrli:endDate>2024-08-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ia7787eb267a142a9a329da33f1e3e934_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report: (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August 8, 2024</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Cibus, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38161</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">27-1967997</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:48.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">6455 Nancy Ridge Drive</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Zip Code)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">858</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">450-0008</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Class A Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">CBUS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia7787eb267a142a9a329da33f1e3e934_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02. &#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 8, 2024, Cibus, Inc. (the &#8220;Company&#8221;) announced its financial results for the three months ended June 30, 2024. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. <br/><br/>The information in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unless the Company expressly sets forth in such filing that such information is to be considered &#8220;filed&#8221; or incorporated by reference therein.<br/></span></div><div id="ia7787eb267a142a9a329da33f1e3e934_10"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="cbus-20240630xpr.htm">Press Release, dated August 8, 2024</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia7787eb267a142a9a329da33f1e3e934_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, Cibus, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated: August 8, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CIBUS, INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Rory Riggs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rory Riggs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Chairman</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>cbus-20240630xpr.htm
<DESCRIPTION>EX-99
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i234bc78a9c1540068f2f5145419c2b45_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cibus Reports Second Quarter Financial Results and Provides First Half Business Update</font></div><div style="text-align:center"><font><br></font></div><div id="i234bc78a9c1540068f2f5145419c2b45_4"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#3a3a3a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Demonstrated continued momentum securing an agreement for its Herbicide Tolerance (HT) traits in Rice with a fourth customer in the second quarter with signing of agreement with Federacion Nacional de Arroceros (&#34;FEDEARROZ&#34;)&#59; builds on prior agreements with Loveland Products, Inc., a subsidiary of Nutrien, Ltd., in the United States and with Interoc S.A. in Latin America</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#3a3a3a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Rice platform is the Company's first entry into the major global grain crops with significant potential commercial opportunities</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#3a3a3a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Wheat platform operational, enables Cibus access into the largest global grain crop in planted acres</font></div><div><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#3a3a3a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Continued achievement of milestones in the development of its Advanced Traits with successful trait edits in Sclerotinia and HT2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#3a3a3a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Added a third Advanced trait prospect with the completion of initial editing for its Nutrient Use Efficiency (NUE) trait in Canola, addressing this new large multi-crop trait category</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#3a3a3a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Continued progress in global regulatory landscape, with recent advances in Canada, the United Kingdom, and a positive vote in the European Union parliament in February to regulate Cibus&#8217; gene edited traits similar to traits from conventional breeding</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#3a3a3a;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Expanded intellectual property (IP) coverage across 10 plant trait and editing families, building on the Company's extensive patent portfolio</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"><br></font></div><div id="i234bc78a9c1540068f2f5145419c2b45_7"></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SAN DIEGO, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">August 8, 2024 </font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8211; Cibus, Inc. (Nasdaq&#58; CBUS) (the &#34;Company&#34;), </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds</font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, today announced its financial results for the quarter</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> ended</font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> June&#160;30, 2024, and provided a business update for the first half of 2024. Management will host a conference call and webcast today at 4&#58;30 p.m. ET.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Management Commentary</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;The past six months have been some of the most important in our history, marked by the successful progress of many commercial, trait and platform development milestone achievements, and critical developments in the regulatory environment for gene editing technologies,&#8221; stated Rory Riggs, Co-Founder, Chairman, and CEO of Cibus. &#8220;This quarter, we successfully completed our edit for a third mode of action for our </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resistance trait and our initial edit for a multi-crop Nutrient Use Efficiency trait &#8211; marking solid progress toward </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the development of our pipeline of gene edited traits. We have also gained significant momentum this year in Rice, our first grain platform, with an additional collaboration for our herbicide tolerance traits with FEDEARROZ, one of the largest rice seed companies in Latin America. We now have collaboration agreements with four major rice seed companies in North America and Latin America. These agreements position us well to be a leader in licensing a new generation of gene edited herbicide tolerance traits in Rice.&#8221; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Riggs continued, &#8220;Our progress is underpinned by our proprietary gene editing platform, which represents a paradigm shift in breeding complex traits, built on over 25 years of rigorous research and development and backed by our extensive patent portfolio. Unlike traditional GMO breeding, our Trait Machine process can produce specific genetic traits that are indistinguishable from traits of conventional breeding, with greater accuracy in materially less time and cost. Although we are still waiting for final agreement and approval in the EU, the recent progress in 2024 with the UK approval to enable development and marketing of gene edited crops in England, the favorable European Union parliament vote on its position on New Genomic Techniques, and approval in Canada of updated feed guidelines that will regulate Cibus' gene editing technologies similar to conventional breeding, is further confirmation of the global movement to regulate traits from our Trait Machine process similar to traits from conventional breeding.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Riggs concluded, &#8220;As you can see from our milestone achievements and year-to-date progress, this year has been about our continued transformation from an R&#38;D-focused company to the first commercial stage gene editing company in agriculture. Our focus is on developing traits with specific genetic attributes to drive productivity. The development of new proprietary traits, the scaling of our Trait Machine process, coupled with increasing global regulatory support, is setting the stage for this new industry of gene edited traits.&#34;</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commercial Progress</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Progress of Cibus' Three Developed Traits  &#8211; Transferring Traits to Customers</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Herbicide Tolerance (HT1 and HT3) in Rice</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Including an additional agreement with FEDEARROZ in the second quarter, Cibus now has agreements with four major Rice seed companies in North and South America to  have Cibus' HT traits placed in their elite germplasm for commercialization.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Cibus believes that these four Rice customers, taken together, represent approximately 40% of the Company's estimated accessible Rice acres across North and Latin America (i.e., acres that would be potentially accessible to Cibus' HT1 and HT3 traits).</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Continued progress in working with customers toward commercializing PSR in Canola.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">PSR field trials for WOSR are ongoing in the UK with results expected in 2024, starting Cibus&#8217; commercialization efforts for WOSR in Europe.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Progress of Cibus' Three Advanced Traits and Sustainable Ingredients</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Sclerotinia Resistance</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Successfully made edits in Canola for the third mode of action for its White Mold (</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) resistance trait, an important milestone for providing durable resistance to White Mold disease in Canola and subsequently other crops, including Soybean.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Now that editing is confirmed for the third mode of action, the plants will be evaluated in a controlled environment with results expected later this year.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">As a reminder, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is a multi-crop trait, meaning that the efficacy achieved in Canola can be translated to other crops, including Soybean, and eventually, the Company will have the opportunity to earn royalties across multiple crops for the same trait.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Herbicide Tolerance (HT2)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Successful completion of edits for HT2 in Canola.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Nutrient Use Efficiency (NUE)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Successful initial editing in Canola for its Nutrient Use Efficiency (NUE) trait, believed to be the first NUE gene edits in a major crop in North America. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">NUE traits are part of a very large category of traits relevant globally to all crops that can make fertilizer use more efficient, without compromising the yield that farmers expect.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Cibus' editing of its NUE trait in Canola is Cibus' first entry into the NUE field. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">This NUE trait is Cibus' first use of its Trait Machine process to operationalize a third party developed trait, demonstrating the Company&#8217;s ability as a development partner to take third party identified gene targets and successfully make edits in Cibus' platforms to develop a trait.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Sustainable Ingredients</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Material increase in funding for its sustainable ingredients effort in 2024 and 2025.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Progress within Crop Platforms</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Wheat Platform (Operational)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Successfully achieved major breakthrough of operationalizing Cibus' Wheat platform, which is one of the world's two major grain crops.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Cibus is actively engaged in initial discussions with potential seed company partners.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Soybean Platform (Advanced)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect Soybean platform to be operational in 2024, allowing for penetration of this large market of over 200 million addressable acres.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Development of the Soybean platform is a key point of inflection for Cibus' productivity trait and sustainable ingredients business.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate and Industry Progress</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Expansion of IP coverage for plant gene editing and traits</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">In the first six months of 2024, Cibus received additional patents across 10 plant gene editing and trait families, further strengthening the Company&#8217;s IP portfolio in its Pod Shatter Reduction, Herbicide Tolerance, High Fiber Wheat, and Improved Quality Alfalfa trait families. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">The IP expansion covers gene editing, productivity traits and quality traits that strengthen Cibus&#8217; patent coverage in geographies including, but not limited to, Europe, Asia, Latin America, and North America.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Canada added to growing list of countries regulating Cibus&#8217; gene editing technologies similar to conventional breeding</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">In May 2024, the Canadian Food Inspection Agency (CFIA), Animal Feed Division published updated feed guidelines confirming that CFIA will regulate products from gene editing like those developed through conventional breeding. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Other global markets&#58; The movement of other countries approving gene editing as similar to conventional breeding techniques continues to expand as momentum builds globally.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> See &#34;About the Cibus Trait Machine</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">process and Rapid Trait Development System</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#34; for information regarding Cibus' initial customer relationships.</font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"><br></font></div><div id="i234bc78a9c1540068f2f5145419c2b45_13"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Expected Milestones</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus has several important development and commercial milestone targets for 2024&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Develo</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ped Productivity Traits&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Continue expansion of the customer base for Cibus&#8217; herbicide tolerance platform in Rice</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Expect our first European field trial results for PSR in WOSR in 2024</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.75pt">Expect field trial results in Canola (Spring Oilseed Rape) in 2024</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Advanced Productivity Traits&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Complete editing and expect greenhouse results for a third mode of action for </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">resistance</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Complete editing and expect greenhouse results for HT2</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Platform Development&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect Soybean single-cell regeneration platform to be operational and complete initial editing</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect to enter into initial development and commercial agreements related to Wheat </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect to initiate the first edits toward developing traits for Wheat</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Sustainable Ingredient Development&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Continue progress to develop sustainable low carbon ingredients or materials for the consumer packaged goods industry that do not negatively impact the environment during production, use, or disposal</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Launch first sustainable ingredient in 2025</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div id="i234bc78a9c1540068f2f5145419c2b45_16"></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Second Quarter 2024 Financial Results</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As a reminder, the business combination of Cibus, Inc. (formerly known as Calyxt, Inc. prior to the business combination) (Legacy Calyxt) and Cibus Global, LLC was completed on May 31, 2023, thus the first five months of the 2023 information provided in the Financial Results, Condensed Consolidated Statements of Operations, and Condensed Consolidated Statements of Cash Flows is that of Legacy Calyxt only. Year-over-year comparisons are not comparable as 2024 includes the combined company whereas 2023 only includes Legacy Calyxt for the first five months.<br> <br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Cash position&#58;&#160;Cash and cash equivalents as of June&#160;30, 2024, was $30.0 million. Taking into account the impact of implemented cost saving initiatives and without giving effect to potential financing transactions that Cibus is pursuing, Cibus expects that existing cash and cash equivalents will fund planned operating expenses and capital expenditure requirements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> into the fourth quarter of 2024.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.53pt">Research and development (R&#38;D) Expense&#58;&#160;R&#38;D expense was $13.0 million for the quarter ended June&#160;30, 2024, compared to $8.4 million in the year-ago period. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The increase of $4.6</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> million is primarily related to increased lab supply and facility expenses, an increase in employee headcount, and an increase in stock-based compensation expense for restricted stock award grants. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">These expenses were partially offset by $1.3 million in one-time expenses due to the closing of the Merger Transactions in the year-ago period.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Selling, general, and administrative (SG&#38;A) expense&#58; SG&#38;A expense was $9.3 million for the quarter ended June&#160;30, 2024, compared to $11.1 million in the year-ago period. The decrease</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of $1.8 million is primarily related to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$6.5 million in one-time expenses due to the closing of the Merger Transactions in the year-ago period. This decrease is offset by </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">an increase in headcount, increased consulting and legal fees, and an increase in stock-based compensation expense for restricted stock award grants.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.53pt">Royalty liability interest expense - related parties&#58; Royalty liability interest expense - related parties was $8.7 million for the quarter ended June&#160;30, 2024, compared to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$2.6 million in the year-ago period</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The increase of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$6.1 million is the result of two additional months in the second quarter of 2024 vs the second quarter of 2023. </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This is a non-cash expense.<br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Non-operating income, net&#58; Non-operating income, net was $1.6 million for the quarter ended June&#160;30, 2024, compared to $1.3 million in the year-ago period. The increase of $0.3 million is driven by the fair value adjustment of the liability classified common warrants. <br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.53pt">Net loss&#58;&#160;Net loss was $28.5 million for the quarter ended June&#160;30, 2024, compared to $20.5 million in the year-ago period.<br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Net loss per share of Class A common stock&#58; Net loss per share of Class A common stock was $1.14 for the quarter ended June&#160;30, 2024, compared to $3.05 in the year-ago period.<br><br></font></div><div id="i234bc78a9c1540068f2f5145419c2b45_22"></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conference Call and Webcast Information<br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus will host a live webcast, Thursday, August 8, 2024, at 4&#58;30 p.m. Eastern Time to discuss its second quarter 2024 financial results and provide a business update. The conference call can be accessed live over the phone by dialing (800) 343-5172 or for international callers by dialing (203) 518-9856. The conference ID is &#8220;CIBUS&#8221; or 24287. A replay of the call will be available through August 22, 2024, by dialing (844) 512-2921 or for international callers by dialing (412) 317-6671&#59; the passcode is 11156392.<br><br>A live audio webcast of the call will be available under &#34;Events &#38; Presentations&#34; in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.<br><br></font></div><div id="i234bc78a9c1540068f2f5145419c2b45_25"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Cibus</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a pipeline of five productivity traits including important traits for Pod Shatter Reduction, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (disease) resistance, and weed management. Its initial traits for Pod Shatter Reduction and weed management are in commercial development with leading seed companies such as Nuseed Americas Inc. in Canola as well as Nutrien Ltd. and Interoc S.A. in Rice in the United States and Latin America. Its other pipeline traits including </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resistance are in advanced greenhouse and field trial stages.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About the Cibus Trait Machine</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">TM </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">process and Rapid Trait Development System</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">TM</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A key element of Cibus' technology breakthrough is its high-throughput breeding process (referred to as the Trait Machine&#8482; process). The Trait Machine process is a crop specific application of Cibus' patented </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Rapid Trait Development System</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8482; (</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">). The proprietary technologies in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> integrate crop specific cell biology platforms with a series of gene editing technologies to enable a system of end-to-end crop specific precision breeding. It is the core technology platform for Cibus' Trait Machine process&#58; the first standardized end-to-end semi-automated crop specific gene editing system that directly edits a seed company's elite germplasm. Each Trait Machine process requires a crop specific cell biology platform that enables Cibus to edit a single cell from a customer's elite germplasm and grow that edited cell into a plant with the Cibus edits. Cibus has a Trait Machine process developed for canola and rice and has already begun transferring their elite germplasm with Cibus edits back to customers.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The traits from Cibus' </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-based high-throughput breeding system are indistinguishable from traits developed using conventional breeding or from nature. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> does not integrate any foreign DNA or transgenes. Under the European Commission's current proposals, it is expected that products from Cibus' </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> gene editing platform such as its Pod Shatter Reduction trait and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resistance traits for Canola and Winter Oilseed Rape would be considered 'Conventional-like'.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus believes that </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and the Trait Machine process represent the technological breakthrough in plant breeding that is the ultimate promise of plant gene editing&#58; &#34;high- throughput gene editing systems operating as an extension of seed company breeding programs.&#34; In 2024, the Trait Machine process was cited by Fast Company Magazine as one of the most innovative products in 2024. </font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Because the Trait Machine process is intended to be integrated into seed companies' breeding operations, the customer relationship between Cibus and seed companies with which it engages is a collaborative relationship in which seed companies transfer elite germplasm to have a specific validated trait placed in the seed company's elite germplasm and expectation of delivery back to the seed company of their elite germplasm with the Cibus edit toward  commercial development. Accordingly, Cibus refers to seed company &#34;customers&#34; in its disclosure once such a customer relationship has been initiated. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br><br></font></div><div id="i234bc78a9c1540068f2f5145419c2b45_28"></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward Looking Statements</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This press release contains &#34;forward-looking statements&#34; within the meaning of applicable securities laws, including The Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included herein, including statements regarding Cibus' operational and financial performance, Cibus' strategy, future operations, prospects, and plans, including the anticipated regulatory environment are forward-looking statements. Forward-looking statements may be identified by words such as &#34;anticipate,&#34; &#34;believe,&#34; &#34;intend,&#34; &#34;expect,&#34; &#34;plan,&#34; &#34;scheduled,&#34; &#34;could,&#34; &#34;would&#34; and &#34;will,&#34; or the negative of these and similar expressions.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">These forward-looking statements are based on the current expectations and assumptions of Cibus' management about future events, which are based on currently available information. These forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and beyond the control of Cibus. Cibus' actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to&#58; Cibus' need for additional near-term funding to finance its activities and challenges in obtaining additional capital on acceptable terms, or at all&#59; changes in expected or existing competition&#59; challenges to Cibus' intellectual property protection and unexpected costs associated with defending intellectual property rights&#59; increased or unanticipated time and resources required for Cibus' platform or trait product development efforts&#59; Cibus' reliance on third parties in connection with its development activities&#59; challenges associated with Cibus' ability to effectively license its productivity traits and sustainable ingredient products&#59; the risk that farmers do not recognize the value in germplasm containing Cibus' traits or that farmers and processors fail to work effectively with crops containing Cibus' traits&#59; delays or disruptions in the Company&#8217;s platform or trait product development efforts&#59; challenges that arise in respect of Cibus' production of high-quality plants and seeds cost effectively on a large scale&#59; Cibus' dependence on distributions from Cibus Global, LLC to pay taxes and cover its corporate and overhead expenses&#59; regulatory developments that disfavor or impose significant burdens on gene-editing processes or products&#59; delays and uncertainties regarding regulatory developments in the European Union&#59; Cibus' ability to achieve commercial success&#59; commodity prices and other market risks facing the agricultural sector&#59; technological developments that could render Cibus' technologies obsolete&#59; changes in macroeconomic and market conditions, including inflation, supply chain constraints, and rising interest rates&#59; dislocations in the capital markets and challenges in accessing liquidity and the impact of such liquidity challenges on Cibus' ability to execute on its business plan&#59; the outcome of any litigation related to the Merger Transactions&#59; the Company's assessment of the period of time through which its financial resources will be adequate to support operations&#59; and other important factors discussed in the &#34;Risk Factors&#34; section of Cibus' Annual Report on Form 10-K which was filed with the Securities and Exchange Commission (the &#34;SEC&#34;) on March 21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, 2024</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Should one or more of these risks or uncertainties occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">statements. Cibus' assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement and involves such risks and uncertainties. Accordingly, the Company could use its available capital resources sooner than it currently expects.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, the forward-looking statements included in this press release represent Cibus' views as of the date hereof. Cibus specifically disclaims any obligation to update such forward-looking statements in the future, except as required under applicable law. These forward-looking statements should not be relied upon as representing Cibus' views as of any date subsequent to the date hereof.<br><br></font></div><div id="i234bc78a9c1540068f2f5145419c2b45_31"></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">CIBUS CONTACTS&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INVESTOR RELATIONS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Karen Troeber<br>ktroeber&#64;cibus.com<br>858-450-2636</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Jeff Sonnek &#8211; ICR </font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">jeff.sonnek&#64;icrinc.com<br><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">MEDIA RELATIONS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Colin Sanford<br>colin&#64;bioscribe.com<br>203-918-4347</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i234bc78a9c1540068f2f5145419c2b45_34"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited and in Thousands, Except Par Value and Share Amounts) </font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">June 30, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">December 31, 2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">30,021</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">32,699&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Accounts receivable</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,058</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">530&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2,020</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,991&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">33,099</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">35,220&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Property, plant, and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">13,764</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">15,775&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">35,603</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">21,685&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Intangible assets, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">34,494</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">35,411&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Goodwill</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">434,898</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">434,898&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other non-current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,522</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,422&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">553,380</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">544,411&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Liabilities, redeemable noncontrolling interest, and stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accounts payable</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">6,196</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">6,127&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2,714</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,747&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued compensation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">3,682</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">3,858&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Deferred revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,623</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,210&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Current portion of notes payable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">404</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">833&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current portion of financing lease obligations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">105</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">187&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Current portion of operating lease obligations</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">3,862</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5,927&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Class A common stock warrants</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">10,379</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,418&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other current liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">16&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">28,972</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">21,323&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Notes payable, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">365</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">536&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Financing lease obligations, net of current portion</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">119</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">113&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Operating lease obligations, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">32,824</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">17,025&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Royalty liability - related parties</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">182,330</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">165,252&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other non-current liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,700</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,868&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">246,310</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">206,117&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Redeemable noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">36,572</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">44,824&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.691%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">June 30, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">December 31, 2023</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class A common stock, $0.0001 par value&#59; 210,000,000 shares authorized&#59; 23,529,689 shares issued and 23,015,417 shares outstanding as of June 30, 2024&#59; 21,240,379 shares issued and 20,567,656 shares outstanding as of December 31, 2023</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class B common stock, $0.0001 par value&#59; 90,000,000 shares authorized&#59; 3,112,516 shares issued and outstanding as of June 30, 2024, and 3,142,636 shares issues and outstanding as of December 31, 2023</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">800,606</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">775,017&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class A common stock in treasury, at cost&#59; 45,177 shares as of June 30, 2024, and 32,663 shares as of December 31, 2023</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(1,999)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(1,785)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accumulated deficit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(528,096)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(479,778)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Accumulated other comprehensive income (loss)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(21)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">270,498</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">293,470&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Total liabilities, redeemable noncontrolling interest, and stockholders&#8217; equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">553,380</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">544,411&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i234bc78a9c1540068f2f5145419c2b45_37"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited and in Thousands, Except Share and Per Share Amounts) </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Three Months Ended June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Six Months Ended June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Revenue&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">838</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">197&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,383</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">239&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Total revenue</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">838</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">197&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,383</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">239&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">12,993</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">8,429&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">25,006</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,638&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">9,327</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11,079&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">16,312</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">13,375&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total operating expenses</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">22,320</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">19,508&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">41,318</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">24,013&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Loss from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(21,482)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(19,311)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(39,935)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(23,774)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Royalty liability interest expense - related parties</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(8,749)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2,617)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(17,078)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2,617)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other interest income, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">169</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">99&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">362</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">78&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-operating income, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,580</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,320&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,211</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">410&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Loss before income taxes</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(28,482)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(20,509)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(55,440)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(25,903)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income tax benefit (expense)</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(10)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(28,478)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(20,509)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(55,450)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(25,903)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss attributable to redeemable noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(3,595)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1,819)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(7,132)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1,819)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss attributable to Cibus, Inc.</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(24,883)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(18,690)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(48,318)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(24,084)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Basic and diluted net loss per share of Class A common stock</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(1.14)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3.05)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(2.26)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6.73)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted average shares of Class A common stock outstanding &#8211; basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">21,851,982</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6,136,114</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">21,357,460</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,576,350</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i234bc78a9c1540068f2f5145419c2b45_40"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited and in Thousands) </font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:75.304%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.656%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Six Months Ended June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(55,450)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(25,903)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Adjustments to reconcile net loss to net cash used by operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Royalty liability interest expense - related parties</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">17,078</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,617&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">3,554</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,191&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based compensation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">5,343</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5,842&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Change in fair value of liability classified Class A common stock warrants</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(1,190)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">371&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(28)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Changes in operating assets and liabilities, net of acquisitions&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts receivable</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(528)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,377&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Due to&#47;from related parties</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(95)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(30)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(24)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(2,270)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,026</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,296&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(170)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,411&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred revenue</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">410</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">251&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets and lease obligations, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(184)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">49&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets and liabilities, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(335)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(303)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash used by operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(30,528)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(14,119)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash acquired from merger with Cibus Global, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">59,381&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases of property, plant, and equipment</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(397)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(560)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net cash (used by) provided by investing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(397)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">58,821&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from issuances of securities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">30,256</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Costs incurred related to issuances of securities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(1,130)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Proceeds from draws on revolving line of credit from Cibus Global, LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,500&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Payment of taxes related to vested restricted stock units</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(214)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(742)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Proceeds from issuance of notes payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,287&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Repayments of financing lease obligations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(60)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(110)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Repayments of notes payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(600)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(273)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash provided by financing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">28,252</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,662&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Effect of exchange rate changes on cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(5)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net (decrease) increase in cash and cash equivalents</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(2,678)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47,369&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents &#8211; beginning of period</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">32,699</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,526&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash and cash equivalents &#8211; end of period</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">30,021</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">50,895&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cbus-20240808.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:89c236c4-fbb5-4d54-a6ca-42af59849496,g:42efc36a-8851-4202-b0b1-6d8ca1098511-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cbus="http://www.cibus.com/20240808" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cibus.com/20240808">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cbus-20240808_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cbus-20240808_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cibus.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cbus-20240808_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:89c236c4-fbb5-4d54-a6ca-42af59849496,g:42efc36a-8851-4202-b0b1-6d8ca1098511-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_20b03d69-2dff-4d6f-ac92-93ca09915d6f_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_7a2d84bc-f211-46df-bc06-101dfc106acd_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_ab2ec460-1c51-4e24-9db5-7000783098fe_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b3354f72-3e8e-4889-9848-7d1a6e2d0962_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c1670c47-d209-4923-81ed-0c51c120d545_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_cc02da3b-46eb-4cd3-be62-4e6b5110082b_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2fd8ead0-37a3-46a0-be1c-8d0466189e77_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_a9313f98-02f9-4302-9af0-cbbdc0e2c96c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_de7471a6-85dd-4ebc-a6d3-731daa1c09b8_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1eef53f9-801a-4a37-9069-747e907e917b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_f2eb64a6-1898-43f8-bb38-66308206a9bd_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_7ca0f052-1c74-41ec-addd-fee3ce129037_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_59038a40-dae0-4bf2-bdfb-69b7e7ea2fed_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_752f9eff-bd1c-4776-a4df-8e60a3fd195b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5cc0a593-5026-4508-b18c-8b7242373032_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_66341da0-837b-4275-b51b-6dfabe531ce0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_492771b3-5894-4c9e-be1e-f79f585f25cf_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d499e9df-5573-4287-a027-c0660633b052_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b4fffbc2-b8d1-4184-bc49-690001224444_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3f70ea1b-657e-43e6-9126-2295dce0e44f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_64d505a3-2390-4049-9973-082573baaeef_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_046da9ad-d794-47af-bac1-696cf7b28ad9_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cbus-20240808_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:89c236c4-fbb5-4d54-a6ca-42af59849496,g:42efc36a-8851-4202-b0b1-6d8ca1098511-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cibus.com/role/Cover" xlink:type="simple" xlink:href="cbus-20240808.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cibus.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_0f7aad2c-5933-4e76-bfbd-1af05ef5beb3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_DocumentType_0f7aad2c-5933-4e76-bfbd-1af05ef5beb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3172d82b-3593-4193-a336-75440db10991" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_DocumentPeriodEndDate_3172d82b-3593-4193-a336-75440db10991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0300d209-5179-403c-a810-ee59270cf446" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_EntityRegistrantName_0300d209-5179-403c-a810-ee59270cf446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_106bac4c-a27e-4cdd-aeaa-8fe0f3a0e822" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_106bac4c-a27e-4cdd-aeaa-8fe0f3a0e822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e3fbab21-8d1f-4be5-8c72-f0e08bc8cca8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_EntityFileNumber_e3fbab21-8d1f-4be5-8c72-f0e08bc8cca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3906da67-e2fc-491c-8cec-e40633065dc7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_EntityTaxIdentificationNumber_3906da67-e2fc-491c-8cec-e40633065dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_dd6a782b-7d53-487a-967f-e06b1f2e880e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_EntityAddressAddressLine1_dd6a782b-7d53-487a-967f-e06b1f2e880e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2ff9d896-9ff1-4688-88a9-8b076aa7d29a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_EntityAddressCityOrTown_2ff9d896-9ff1-4688-88a9-8b076aa7d29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_37a535af-b281-486a-9487-bcf553894a50" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_EntityAddressStateOrProvince_37a535af-b281-486a-9487-bcf553894a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e13dc7a8-91b8-4fb4-be6e-8d3465c2b0f7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_EntityAddressPostalZipCode_e13dc7a8-91b8-4fb4-be6e-8d3465c2b0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c9295405-1b51-4d86-844c-409925bf6cc8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_CityAreaCode_c9295405-1b51-4d86-844c-409925bf6cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ba0ba2c0-bb00-4904-8262-80cfba68e317" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_LocalPhoneNumber_ba0ba2c0-bb00-4904-8262-80cfba68e317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9f10d957-7152-4cfa-9827-6d2ab018f7a1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_WrittenCommunications_9f10d957-7152-4cfa-9827-6d2ab018f7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_0b2f69a9-aee6-4835-93be-c37e314edcb7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_SolicitingMaterial_0b2f69a9-aee6-4835-93be-c37e314edcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_47ee9b87-e164-4ddd-ad54-a6b7b711e25a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_PreCommencementTenderOffer_47ee9b87-e164-4ddd-ad54-a6b7b711e25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_03ccf5ee-0ace-4018-8302-ff340de1e0a0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_03ccf5ee-0ace-4018-8302-ff340de1e0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3c5f7e44-43d5-4a99-80e4-63499655a65b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_Security12bTitle_3c5f7e44-43d5-4a99-80e4-63499655a65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2901cfd0-f762-47dd-b5ec-c26f5bee9645" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_TradingSymbol_2901cfd0-f762-47dd-b5ec-c26f5bee9645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_94e661a1-3f9f-4005-8c81-d83368540493" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_SecurityExchangeName_94e661a1-3f9f-4005-8c81-d83368540493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3bc0834b-b35d-4580-b6d0-d937c272d014" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_EntityEmergingGrowthCompany_3bc0834b-b35d-4580-b6d0-d937c272d014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_919c07f3-2848-470c-84ba-31abbc70684e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_EntityCentralIndexKey_919c07f3-2848-470c-84ba-31abbc70684e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6cbb6db3-af5f-4de7-a2d4-1b390660474f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_8c8bafde-9f33-49c2-b98f-a28856f055b6" xlink:to="loc_dei_AmendmentFlag_6cbb6db3-af5f-4de7-a2d4-1b390660474f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>cibus_logoxrgba.jpg
<TEXT>
begin 644 cibus_logoxrgba.jpg
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M  (1 0,1 ?_$ /(  0 # 0$! 0             %!@<$ P(! 0$! 0$! 0$
M            !00# @$&$  ! @0% P0" @$% 0     # 0( $ 0%(#! $3$R
M$P8A$C0U4!1P,Q9@(B,5)201  $" 00-"@4# P,#!0    $" P @$2$Q,$!!
M47&QP1(B,E)R!&&!D:'1X8(3(S,00F*2LE"B%'#Q4V#P--)#8W.#DZ,D$@ "
M  0' 0$            1(4!08'  $" P@) !,: 3 0 ! @()! ,! 0$
M  $1 #$@(3! \$%187&AL1"!D<%0T>'Q<&#_V@ , P$  A$#$0   =4
M             'SY!8<41DQ^?GSW=^]BH4>CKT
M                                                   K,R9 3\
M]??JZ6K79V[
M                       "@P('AS\ >_3WU=>OCX\7FY<_?OT
M
M  "DQ(G!GX 3V_?9:5&A085EITIK;M
M                                          Y./&H2)')QY='3I<[5
MGJZ]:O+E\_/G<+%@
M                            #S\^?3UZ A<.*O3Y][O70
M
M   (G'DJ\R7?K]\
M                         "*R9(W-F[>_>7UZ_OUZ $%@P0F+%>+EP
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MTY^WG[X^GCK\>_OY]^_BX8=H  $1WXYK5F1'?B     /OY]UN)7FN'<
M "!P8*Q+F"8V;+;7K<O'C1(4.^W[W1TZ      "-Z\L9O10   /3Y]T271N&
M':        !DMJ1 Z<X&O1+$UG[@   "G[L6;U9H%UP;M#ET0      !7=6;
M+[$OQ^^0   +%ETZE'J^GSZ  ,UK3+W-WT.E/T.72S2M,TZ13RZQ+U:-6  %
M3VX\WJS?/[\      &KQJUARZ0      (?'CJ4B2/WZOU^_"XL4-BQWF[<
M     C>O+&;T4    ?IIDBI:\>L        9+:D0.G.!KT2Q-9^X    I^[%
MF]6:!=<&[0Y=$      ")[<<BN1_+[\     M>/7ILBH  ,QKR]#ET<\J3OQ
M\FL_>ZX-V36I&LQ:X %.W8LYJS?P $CRZ6K'KF\_?NY]/OXY/?F'[\*SKS06
MG/\ @-7C5K#ET@      1&/'49$D"V5JT#@P2>K39*5(      "-Z\L9O10.
MOQ[MV+7\'!UYU[3G\?7D#H\^MG@VNGQ[        R6U(@=.<#7HEB:S]P
M!3]V+-ZLT"ZX-VARZ(      &2VY$#HS@?3[<L&RT8]?7X]<73Q4-V.J;,@
MU6-6L>72 !4-V,0>CAH\JEFE:7;<6R#T<+]-H "NZLV5V9/R ='GUH4NC;<6
MO]?0  (GMQSZI.KVG/J\:M8<ND      "(QXZC(D@2^S7$8\EXN6^WOW
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M\=1D20!.[]UHJ5       !&]>6,WHH$OQ[;#"L@ 8[=C1/;B/7Y]W/\ .W@
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M>[6[8       $;UY8S>B@2_'ML,*R.?UYJVS)G].?X>O(]OGK9(-GNY]
M    ,EM2('3G UZ)8FL_<    4_=BS>K- NN#=H<NB      !\OF6V95;U9@
M !-Y^]RP[;3BU?3Z       !#=^&07(X$SP[:_#L@              "(QXZ
MC(D@2VO5;[%@       "-Z\L9O10/M]Z?'KS^_/#UY_ #]-1CU;-DU
M  #);4B!TYP->B6)K/W    %/W8LWJS0+K@W:'+H@      #Y^_,]ISJ9OQ?
M@  )#GTT*71LV34       *YJS959D@63+IU2-6               $1CQU&
M1) F=NRV5JP       $;UY8S>B@    2_'MH<NC/9M        &2VI$#IS@:
M]$L36?N    *?NQ9O5F@77!NT.71        $+WX4.E@KVK-^   M^'9H\JE
M]/H      KFK-E5F2!9,NG5(U8               1&/'49$D":V[;76J@
M     1O7EC-Z*     /HTB33MV+8       ,EM2('3G UZ)8FL_<    4_=B
MS>K- NN#=H<NB         (WKRIN_%4MN3P]>0 +9BUZ9)J      "$T<,BM
MQP)GAVU^'9               $1CQU&1) FMNVUUJH       $;UY8S>B@=W
M/I>IVX?/UR^_$/WXU_3G\_OP#[?==AV)CAV       R6U(@=.<#7HEB:S]P
M  !3]V+-ZLT"ZX-VARZ(          \?7FF;\5&HX?'[Y &IQZMER:@
M.3WXQ+]!# ]?GW<?SUWZ^?0              (?%CJ4F2!-;=MKK50
M (WKRQF]% E^/;885D #BZ<\ML2H;OQ L&;1K$6N      !DMJ1 Z<X&O1+$
MUG[@   "G[L6;U9H%UP;M#ET0          !&]>63VI/#TY@3N?OK<2P
M  ,6OQ.#IS U:-6L672              !"XL54DR@)K;MM=:J       !&]
M>6,WHH$OQ[;#"L@ #C]^,9OQ?'[Y'Z;9^?N=?CV      ,EM2('3G UV)8F\
M_<    4S?BSJI- NN#=H<NB           ! :<^36I 'T^[C^=N>OST
M!G-6;3=V("QY=.JQJP              $+BQ523* FMNVUUJH       $;UY
M8S>B@2_'ML,*R  !E]B55]>4#5XU:PY=(      RFS)KNK,!J4>K9LFH
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M6   /Q\Q']##YO7D#;OS]SJ\>P     !P].>.78WAZ\@=OCWJD:M+\.P
M\OOG-ZTVV8M=ARZ0      (C'CJ,B2!-;=MKK50       (WKRQF]% E^/;8
M85D  0&G/D]J1^ _3;?S]SJ\>P     !Q^_&*_H(GR^ :C(JV?'J   % ISZ
M-0P =_/IM,"V      (SMRQJ[% ^GW:(%KNY]  !6M>7++$H#NY]-J@6P
M   !6=>7+K$K\ /3Y]O,[?=<&WV\^@  *SKRY[4G1_3GJ\:M8<ND      ".
MS9J7%C 36W;:ZU4       "-Z\L9O10)?CVV&%9 'E]\U/;DSZG/\?7D"Q9=
M.K1JP       S2M,J6W&![?/NFR*EER:@ !1Z&"@4Y_X :-+I7+!M
MQZ[&B.W$"<S]]6C5O;SZ $;UY9+;D<?OP!=Y^[09E$       "G;L6<U9OX
M#W\^K)DTSF?OW<^GT<_KS$]N59V98SKR U>-6L.72      !Y^/&?P('Y\":
MV[;76J@       1O7EC-Z*![?/4QG[#\^_.?UYC>O/X^_ !Z?/NO0[$MQ[
M     #E]^,=NQN/WX _2?S:+-DU2'+I\D7VXU7;EB>W$ 3>?OKD2O^OH
M  %8UY<NL2@!W\^EPP[);AV^?OR"T<*?NQ^/KR!T>?6RP;77X]@       "K
M[,F:UIGC]^      #5XU:PY=(       I<2+'9\XFMNRUUJP       $;UY8
MS>B@    #Z?=,D4[5CU@       "&[\,HM2>?UY     $ERZZW$K]?CV
M   !E]>55]F4    #Z-/CU;/DU         ".Z\LXJS:_IS@    #L\>]8BU
MY3CU       $3DR5"/($GJTW*S9        C>O+&;T4    #M\>])DT[%ET@
M        "*[<<OL2XSKR    %AS:-.D5.GQ[        'G]^9A7E5K7F
M]?GW2I-.TX]8          $#IST_=CK>K-X^O(  ^GV<S=[9BUVK'K]/GT
M      5"/(B<F3[]?;U=N]'3H       (WKRQV[&  'T>OGUV>/<GQZV#-HM
M.+5Z_/0          ^/ORE[\5-WXN#IS  $QP[7:?NM6/6          *CMQ
MT:C@CNO, #[^?;-DTWZ;0D>74            ?+Y%=^4;UY<WOS\G1Y^]_+I
M+\>WMY]          ?'GS594J'QY/7WZE]>RTU:@
M     $7VXQ/;ES>_/Z=G/W,<.W=SZ            "*[<8GMRY_?GZ^._GTF
ML_?H\^@                            (S+EC,V;T]>K%1H@
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M.0RD&M-<*A3?E2VNWEA_CE L+XQ3PGC--#/'K<V T-&'5FM=O-#_ !N@6/\
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MYA\5%I/>'\1(8P'&;&UOY#(>W1CL\VTL#+DD-).JG2/-+*32#01"L]<W#SZ
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M )C^%,Y.>U#V+4RA;<RQSO.]6R<;;%I,_P!U#3%NPCO-/(W%>'W@@/@O+Z_
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MDDDEVT>DDDDDDDB__P#_ /\ \DDDDDDDDDW_ +))))(_^)))))))) /_ /\
M_P#I))(,UFI))&O_ /\ _P#_ /\ ,DDDDDDD&UD4DDDDDDD7_P#_ /\ [TDD
MDDDDDDF_]DDDDD?_ !)))))))&?_ /\ _P#^)))!@^/)).__ -FR[Y_F2222
M222';;62222222+_ ..&_P"C))))))))-_[))))(_P#B2222222#_P NHO\
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M !))))))).?_ /\ 0\DDDDDDDD?_ ')))))))))))))))(=LY)))))))(O\
M@E_^J222222223?^R2222/\ XDDDDDDDD+__ /\ U22222222;_F22222222
M22222220[:R22222221?_P#_ /\ \622222222;_ -DDDDD?_$DDDDDDDDG3
M_P#_ -.2222223?^R222222222222222';:22222222+_P#_ /\ _P#.DDDD
MDDDDW_LDDDDC_P"))))))))))%=__P#R222222#_ -DDDDDDDDDDDDDDDD.V
MTDDDDDDDD7_3<-7_ !))))))))O_ &22221_\222222222226C_\R222221?
M^F222222222222222+;:22222222+_B22%_^R2222223?^R2222/_B222222
M222221K_ -DDDDDDD7_LDDDDDDDDDDDDDDDNVTDDDDDDDD7_ !)))A_]))))
M)))O^)))))%_Y))))))))))))%_QY))))))/^I)))))))))))))))=MI))))
M)))(O^)))(?_ &2222221?\ \DDDDF_^DDDDDDDDBDDDD/\ ]))))))(_P#^
M222222222222222[;222222221?\2223_P#LDDDDDD@_ZDDDDDW_ /))))))
M%6I))))/_9))))))%_[Y))))))Y)))))))=MI)))))))(O\ B222;_V22222
M21_^R2223[_B222222/_ -DDDG/_ +))))))(M_R)))))'3)))))))#MM)))
M)))))%_Q))(G_;)))))))I_Q)))(/_!))))))!_XI))+_P#22222222*_P#>
MLDD@QYDDDDDDDGVVDDDDDDDDB_XDD_W_ %))))))))/^3)) W_Q)))))))!_
M[9)/?_Y)))))))([_P#[M%X?\R2222221G;222222221?^;5[_\ 7DDDDDDD
MD)_[L&X__P Y))))))(O_P 57;_I222222222$__ /\ _P#_ /YDDDDDDDD6
MQDDDDDDDDB__ /\ _P#_  I)))))))).O_\ _P#_ /XI))))))))_P#_ /\
M_P#G2222222222,__P#_ /\ _P!DDDDDDDDDVLDDDDDDDD7_ /\ _P#_ #9)
M))))))))*/\ _P#_ /R9))))))))(_\ _P#_ /;)))))))))))*M_P#_ ,VD
MDDDDDDDDFQDDDDDDDDG_ /\ \X >222222222202?_\ _P")))))))))) O_
M /\ 3,DDDDDDDDDDDDC#&?LDDDDDDDDDD[U4DDDDDDDDDDDDDDDDDDDDDDDD
MDD/$5DDDDDDDDDDDDD^7&DDDDDDDDDDDDDDDDDDDDDDDDDDDDDA-DDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDG_V@ ( 0$# 3\0
M_"NG *C !=6B"Y15)\A]%33E#A[QY5+ 9G,#X"5N\=1U,L_2FZ5K)7=]EO\
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M46=?JB/A@9L1[[*_"B@%MUG6#[U+9_'I(783*YP"S[Y1"V)"2-W)]L#RC/\
M,=.C("Y\,C$2WV&?!*:N,'#Q9W.B!QI%(0F2-QQY9"SA=TW2X7-W"@\@0 $B
M%QTXL,1G.1@,NISWA"E^7*(VS^/2G_(@H)$3,1IR L$!,^1,^3._YGIT9 Z,
MVR]XY63A(J*T9D9\CS:-CJRVAOED.9EBF!PW];+O;-SU3IF+,FL3$KV6!$(/
M?0N_Y<HC;/X\!@O1$1%D@F[U,,==S-!1T*"B!=T/O*9T)EDATT>0:2VT*ES
M3 ^Q)X2D$LC3<(F40#(G S.<F[\UTZ,@O<Y*9XDV>93(^,SY-GR$^BFBI"0<
M'F.Y,G#>\Q,R9O%(7TEOIF,0FY1XL'9MB9[E<Y%K&)\/X"$Q:]_ZU:-L_CP;
M<XL2.$B!F7>&9TL[QH$ZA0( 7/\ JN8)P[ ;"[W*P3P7\YTZ,@30>QCHGY%D
M]<Z@YW0E7+N>SE@F$B'<C!/0O3IEQ@B,[OE@E1H4YWE'"1[GY:-&V?QX-N<6
M/@<ER/YB^3*N#XG)2CDQD^H)U @PB61K/6TVY"/M,U/HS" SG%SQHT("..G*
MGVP;_6@?D13()]NR. P(*,/<21^:['/0CSIEA.$NB+U 8$2FH6)69T4N G\M
M&C;/X\&W.+0. 0%M)V!<$@RD+P@]HZ>[>^N67P0#97N2IH\$+F=Z\ G;Z?C*
M6HE 58"[32A!Y91%.:&^@ODT.D&O/'BP9UK&8Y.FE@>0[X5!S;W:1%$A+F"8
M*-UD,BXO=SW_ )6-&V?QX-N<6@<>Y&5A'EJ>I@X*'B;@!SF3B@13VC1U/G*M
MH'Z/M@=HB+G")^7IGX8M0L+LC$+T@B-SQZA7%DF4@QL4122@.Z7HV'L4<UG#
M=;0ZHI YY@'N8%<97(<,KSIXQ#$'$\B5Z3!;!G"^+HR'O#)*/<<2RTL\5[G6
M0TELVGH+/);#+&!<R_#1HVS^/!MSBT$1F@9ES#!;BT1P(/:>G2;DQ%LTKTGO
M@GEI=8B)<A3IHNG1F%4<\LJMJ=\%('(F#!U11\L9YA'MIEF1=;R:O2%@*8A*
MRG*&@P0%59 !*M7=@ =PQ/8< &0(YJ=S3Q:H9>6TNEGB24AE/<Y+([PS'>8-
M\,8*[@25_3.B0911)OYON>\:,?>2B X!O5W!FT%/\RX71?X,W?PU%]*XG/.&
M1]ZM&V?QX-N<6,#*D<*F26X^3W4@11*N:KZO66 S5<@*#)I<+)1^\G3P-DJ6
M'-=4I%=U(J ]$P&! &6>6#B$'SWZ&#.ZF2\CQE[L&YP" H4IXM'*QSHZPP&0
M!D!II0R@NN&=7S8'*%+=$B=&E-(HN2]FSE#C$4&!S.2=5'F\L /@X<Z?V1J(
M1@CA@BSG\S]N$/V4B$(F2(X)/>'.-XF=-0@R)@\P9=:K7.2F>#%GDXT" )5R
M *").'M%2,<)^U2 );5N[[V5WNI/LJDPWRO+5HVS^/!MSBPH /\ >"*GHLR#
M<08;X.;3EJE97<!N ,@,C!D-PC93YT^Q:B15= R,\![L %KKRK>XF2-RLOV)
M$CBEEQL\)Q'0.K0 9JK499K^393]$XKBJ4E<U;K@S$K(SE-E1+?J'22W3('7
M/MP/P2 ',BTWQ;F7!"GS*).8[Q-XYF%#$+-(G!N&\R.N52Q1 6UKS/>]W!>%
M0=Y O9-2*Y9($('^L_H_92(0B9(CA$#6]J<&',Y-% UYP>Q6&'-Y">J44E#G
M%'M'H^Y&P!;[OATP9WGV%<@B9R;\DPD.,G5'Q,6E^$Q-( A(1W)JL;9_'@W"
M'63*84]SUZZA@%\P^1:(0(W'NK77 ,W5%P@S"V4X#JU[-&06/!R?._49*$(-
MCG[P5*%>3,RY;A^L%LRB<9,D)P-!RE0X4(-KKD]5V*"H7B)\A4G3P%\=)!]D
M#FYCXU*&[(4<6D*QYW"M!PLN1N7[$M&7 ) $ < U /;5,S\S"/1XX4I%DEIQ
MLW6YN:&O+(SUU\M&.+&-N4]ZY>0A[QWHA[D0'S'.ZHJ^B.N@38-P9&"!)6Y$
MW3<&:\*S+10H4S3FBZF<6(W#O;^SOXB_)A(#]CN3)_ /E.067=&8>T_4 US3
M.LFI;/X]*%E@*@P &:M$0YF9@LR> YMUC?.I3C#J@YG-AO%[7."T08X?<ADF
MY-+E]N,J&[Q7N=)2ZLT19<%U_#(U&^35_'8,LXH+7OU$Z,_Y %!  9JM$HF.
MN&?.#GQG[==4%Y>2-+^0YI*?4G(Q%U'KSYM+%8T!1+OB>\T\<)<S2(A,3>-1
M6Y@ NOBCX>I&H4O-2?*-2V?QZ0(;1%DG>,CSNI4P,X7"%'PO-Y6U7(1.4)KP
M\7>NSG6>ZZ3!\MSF9Z,-Y P0[QOT.=J+QF&,UD-\D7U-QX )11I.(),CE#NX
M6\8T2.#ER.APWM9Z<2<#2W<?#BZNO/DK%SD5R[ O&AD7>D/-(^6O8,P' !CR
M^SI(\@SICF)Y/@UPV+-F!YBRN@Y5:GYIZ &IO\RF!D^:^7\>BG2XX))1'H$3
M9[_H:B3"@@)5G6SWU6SWU6SWU6SWU6SWU6SWU6]2TBQ[%0N:,%T.BIH,D1%?
MQE&])+<TH] M3, !![*(?'I5@5DES@WN]U<B 0XW-2441Y9TO#XT.HIT%,$)
MNGG<?'%VQ\2$/6H%D83"9Y9_'0  " ,@#541@$0D1N)4U($"JX!V24*B[ <O
M")_8YXFM]"SN!(M0#K"P@< 3Y3HTIAF%OOA.@<M;M ,9NH)3R9GB[O@/:F5X
M,*/D=Z<D3O\ HB@!)W@!CKG2 M.(CVGWIH!+C_JZ4@RN7>L35BJ/N1*O'' D
MN +.9[^CQ$R3@3@+/O0NQA>(")L7?^50"$CDC9*OH(DKQ42]:=5><=Q#WI*=
MS1;Y#PH2P^4>]WI?$HN9JH*M60=AOK2 0D<D;)3@+.35>*DGK3*C;#?M0&*/
MN"S\D4ADDY[A[U+%D"\GG+?%2Q$B7/4!??\ .!HKEE>@2]%23@SO92_8"7Y;
MHJFP;_\ UW__V@ ( 0(# 3\0_"K%*0)<=W]K@CI0>_5HP^']5.'^_P#BCNY%
M_P!89 0U,R^\_P")LAXL .\T#+/B*0A;?TH )9_XD_ .9[X)^%(^:%E9I%>Y
MJ8=_!_XE V^YX4UDRX[O1"#^J A[]?2/@7BHTX$^_P#BG)/B@CUF+PI$O)_Q
MA=Y7;//_ !!F!*SK>161![MOB@94F&'B'Q_M1OG/QG_Z=B O2LF^K&3KIKX-
M7:.I_4T^_M_M&^5;(5N:H]AZY?NN.NF?]I!ARU%&( RSH&4DY>DN8K@H7,$A
MX'FI'P/.G!6"O\QK_,:_S&O\QK_(:0N.LB2).E?YC7^8U_F-(H<G1V@M?YC7
M^8U_F-6XGMJE_([4BP=_U6]JMD*W9_%;H;.=-0$=''+6X_=9'S'#(^:Y:LF,
MWN4@[7'I2:$)R*SO+[_%;JESS_FA.@#6;*7!M^_-(0?UJ(9?$/0!<* GUYJ-
M0OB>-G3]NQW &KJ#IEXHK^P_NE(,>-5\[RP;'IH]DYX.^U)6!EQW5F:=3]8Q
M8$E1[+VI!AOH!E>)^J8;YO\ JLSV^A[=JA)$\FFW$VY-&8M=U_N@5RRXJ)R3
MQ;]* AS*8A!EJ'1C'S_GKG7^GIT \^G*0T_;M$9 DIMZWCA_-4\[RP;'IH]D
MYX.^U%G8\^E0(@-$#)EY]:=*(3'&WC3J0U<H-O?%/+<YSX491N:!WHXWW?S_
M )0B @-/<]O&H#+T??J*,E<T"HCW:ZP>-0[=I.)7LZGYWE@V/31[)SP=]J#<
M(O1@&0:3@5[F.2/!5$'BK.>$T<\ENI(LGPWGIFCD'C%;/(<?YBN7/AOH?W?K
M^U8&.A^Z5_=0/[FO\Q1;3TR_=9-,N>T8+GMXU#QOO!,<2IQN,CVK,]G]_6H=
MNP249BMB_P HWZ^:N4]1^IH65)@46&F=W-2\[RP;'IH]DYX.^U""ZC@4"6L@
M'5NK@CI7^LUQ!UI;])AF*XHX8A5_Z*>%S.O]J[1R%RC0_AWFW*DE3B_JC@'5
M^L.;6>_*@C(P2 @K)^HW_P I9OH+DRX-JR!Z'Z]+GMXU#QOO!+-C;[](QOO\
MZAV[!VN"7,-#P#<^\$"'1^M2\[RP;'IH]DYX.^T_.!PK-9>^)\WGN?KTEC!6
MX1QW_P I59<2#)>OA8X]*O&3AME7,T]SQ[U\5'VTZN. 7OJ)VC!\?#C4N]AP
MTF^3BWG[H%1D0\:AXWW@$$5S$?\ =1[=@[7"P'=XH9)/6/<"?C4O.\L&QZ:/
M9.>#OM/-/@OU@91=R^<:1DO66@Y^%2YET613#GM-97[*R,?92JRX<W?P_N!'
M:*V"&O>-]X9^!/.H]NP=KBG?+QEZR!Q-2\[RP;'IH]DYX.^T[S=7DP&?>:U$
M[N_I0008,D.5^]?\;[PYKQ?S4>W8.UQ&/<\OJL&I>=Y8-CTT>R<\'?:>(YR8
M =[Z47#681-^1]X,K.!^_P !XWWAY&!J/;L':XN6 >LDY.I>=Y8-CTT>R<\'
M?:=2%RB(63 %P%FG(/ZUCHAYSP3INR?O\!XWW@Y^)J7;L':X4F?TP1$7S>Q_
M=2\[RP;'IH]DYX.^U#;GQA,@25F#E\E65EQ,S5>="& 46XI$KO\ P'C?>#WA
MX-2[=@[7ULY:6G(X;Z,! >J*P4Z/8U+SO+!L>FCV3G@[[4$&2]"=Q[X[J0\3
M*L_RN](,.3J4FSNP3GEYR_ ^-]X)CR'4NW8 2&U?YA0-A\85BI6X]]3\[RP;
M'IH]DYX.^U%%)DUN1>.[WX>- !!]]]?WP-1.3H^,#S=3\#XWW@&;J\FI=NTE
MJ9\2]9[[O[U+SO+!L>FCV3G@[[4\J&>!K*5ZG[T 2RN#<_VD4-].\G1P'-U/
MP/C?>"]LN:EV[2I.37=LX?S4?.\L&QZ:/9.>#OM5N3+ANI>0ZBVWS14H3%'W
M7O\ W3Q>YX<$9Y>,_P #XWW@O;+FI=NP(#<*V1K9&C?=RO\ =_E7]>JA$C)@
M!(;4D6];4/.\L&QZ:/9.>#OM75E0TUC[GZH&23#ES^F_3<K$P"BWE(D=WX!9
M.CPX+VRYJ7;L':XD)?ZJ0&0N8)9.)^]0\[RP;'IH]DYX.^UF?6;SCAR3O'-\
M?S3\]#!.N[-^_P !:V6<%[9<U+MV#M<9'=4!"S@Y8.G\[RP&/8\&C.=RP=]K
M3F/ ?IP))#4IP.FG3_PX,S.)^_P%K99P7MES4NW8.UT&4\4?>"!<X\:=3R)\
MX()\0_6CR'T^\"R/7ZU*X"3H>= 8(NNTT8K6>F'_ "2Y:_:V6<%[9<U+MV#M
M= <SG]8/"^]/.SA@>-V[Z/->)?KZP2\ >=-(\-+^BK\/4_J*L(>U=.,?/^:$
M_'@4]?3Y\_ANP,[#4C6W/'3(P(=0M;+."]LN:EV[!VN@@9OF^?Y@D7*/&GA7
M \8)(+F9[:)"%VB,;C!+O;XTT'$'C_<'3V?Q_- $URL P<T%YTY@[%&+#@W-
M*?SSW'1PHEK?+VE7/;QJ!GVOO!>V7-2[=@[7&D[;?]8%BN:#I^5+0)); G\Z
M=#'M.N#E[YI9TW""?.6!!(:9'L8\Y<3WW8.6A_FH\0/:AP&(22MY\7Z?W2L"
M'09U]CXHR#^_2Y[>-0Z(CS@O;+FI=NP=KA1@*\J>G(X;_P"4:" P2@<#]ZCF
M[^'\P(@D:>_@]?WB":=0\MF?ZPQ@M=U_FH06]9ZX!X!M^JC!#ABUF]X41P40
M&_-U+L \/Y0X1X E7 ]VWS1+#V_=);CYKD=RDWA[T?ZJXF<=^"Y[>-0D^(BD
MCUO;+FI=NP(K#6V?VK;/[4#_ $_NK%YJ 0$80"MBG;V-1%WB@=IPYS$N7ZH%
MA[?NGA'R4C<'O7ZU5N9\6^$^?M^Z5674,T?TW81(,^:7]VWU26X^:1<#WH6:
MGD;?JA8(,"BP4[/?J>]'QJ1$CI[GMXU&5X9OG^^KS;+FI=NTJ@2U)W?O_-3F
M-U<HPDCI=YS<<:0W-2X5>YM?2+&;7 #WU5&5EPW5D7L/UI39<42FVHY0_AO]
M8SG)J7;M)+G%9:_;UU63%MY0LK/AOT>3G1_=3XEU-V)"4!8\^GZT1,J"FW/S
M_FL9;/(:XZ=J%E#TQJ!+6_I<L_Y60&'RTY*EU/BQ[<OUZ. N49_PU'LU<ZN=
M7.KG5SJYU(;RA7^0J_'SXH%IV<ZR@^32,J75W4J&D,C/,_56^?/QCNK+P,ZR
MS[VKY'D<=_\ :\.;\0!+D5E^;V^:1E>V[6T&1BK"O?/S0;R]O[1OA7+4JP/G
M]UPATK-TO75D02-)?M3T6EQ3&8*+&_I^6M:\^:+>7M_:.$IW7<I]H.A^YJ_#
MK=K7OGYHEQ;=:.&K<.Y6] Z%7,O7\XVS'4#6ZD]_XH](3D97^7_UW__:  @!
M P,!/Q#\*L4A ZMW]KACI0._5LP^']41+_XHKN1?#("&IF7WG_$Y@\6 7>:!
MEG1 %M_2@ EG_B2IP<SWP3\*1\T+*S2*]S4@[^#_ ,2@;?<TUDRX[O1&!^J
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FNXCQXI=D5SU&\7:MW3U:L8/SC><=0-;J3W_BCTA.1E?Y?_7?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139665591398016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  08,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cibus, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-1967997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6455 Nancy Ridge Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">450-0008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CBUS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001705843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ".!"%D'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  C@0A9, TN'^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)^W*HJ&;B^))07!!\1:2V=U@TX1DI-VW-XV[740?0,@E,W^^
M^0;2Z2"TC_@<?<!(%M/5Y/HA"1TV[$ 4!$#2!W0JU3DQY.;.1Z<H7^,>@M(?
M:H_0<KX&AZ2,(@4SL H+D<G.:*$C*O+QA#=ZP8?/V!>8T8 ].APH05,WP.0\
M,1RGOH,+8(811I>^"V@68JG^B2T=8*?DE.R2&L>Q'E<EEW=HX.WI\:6L6]DA
MD1HTYE?)"CH&W+#SY-?5W?WV@<F6M]<5O\EGVW+!;P5?O\^N/_PNPLX;N[/_
MV/@L*#OX]2_D%U!+ P04    "  C@0A9F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M ".!"%D3^H+$200  ($0   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
ME9AO<^(V$,:_BL;M=-J9$%L.?U-@AD#29NXN1T.N-]-.7PA;@":VY$IR@&_?
ME2$VG3-K[DULV=Z'G[2K1U*&6Z5?S89S2W9I(LW(VUB;W?J^B38\9>9:95S"
MFY72*;/0U&O?9)JSN A*$S\,@JZ?,B&]\;!X-M?CH<IM(B2?:V+R-&5Z?\<3
MM1UYU'M_\"S6&^L>^.-AQM9\P>V7;*ZAY9<JL4BY-$))HOEJY$WH[5W8=@'%
M%W\*OC4G]\1U9:G4JVL\QB,O<$0\X9%U$@PN;WS*D\0I <>_1U&O_$T7>'K_
MKOY0=!XZLV2&3U7R5<1V,_+Z'HGYBN6)?5;;W_FQ0QVG%ZG$%'_)]O!MN^V1
M*#=6I<=@($B%/%S9[C@0)P&=X$Q > P("^[##Q64,V;9>*C5EFCW-:BYFZ*K
M133 ">FRLK :W@J(L^.I>N-ZZ%N0<@_\Z!AV=P@+SX1-\O4U"?I7) S"]O_#
M?2 H,<(2(RST;C ,\O=D::R&1/U31W10:-<KN.J]-1F+^,B#\C1<OW%O_-,/
MM!O\BO#=E'PWF/IXIJ(<:M&2EWW&Z^#P\'[K P+1+B':ET',N18J)O<R)I#T
M6AY<J4A?D;^F!'9*M@ZJ>"^ML'ORS-?"I1 @GUA:2X;K3,4R-U?D44;7"%6W
MI.I>0@5J2F=*,V<$5V1A8="(TF2J<FGU'JYQ+2HN/KM'"'LE8>\2P@>1</*4
MI\OZR8AK! %MW?1IER(\_9*G?PG/"]N1QQAJ3:Q$5 P;0H<KAKT6'71[@T$/
MP1N4>(-+\"9Q#',<ZN1X0S["=^2SK,TBKMAM=SI0JS*"XA7QFI.9AF4"0:5!
M9:W!=\%.70O*[D5M9:WEXG(+)LE,\+7"X$Y\GWX77#DIYEJ]"1G5#F6#YG2"
MH55K 46M_!NTN3*6)>0OD9V=J0V*@Y"&V.R@U3I <2<O<CB!_<]YE(:EH-/'
M0*JU@.(6_E%%,";SC9*8<32(M#M!*P@"E*A: 2ANW5^UL)9+&)@TS>71-DPM
M%2ZT8HE!9V!E_Q2WZ(5*1"2LD&OR"<I;"Y;4\N JC3R5V5/<J>>:MR(8'@[S
MZ["=X#*&C<_GU>I,_G"]1K+*]BGNTM^0/1J3 UDC("[;"%@9/\5]^D586"+5
MBM#PY^4O9,&C'.IM7\N$*TT3!BO&I*A36-<65D6O5^3'X!IF B49T^2-)3DG
M&?3;;)C&^,-J,0AQ]W[1+'9UN-BG2U5;A0T"T[LO"XRD<OX0=^GWH2/WNVC#
M)"QYY[9J#4)/D\5L\@?&=++]O\CR[U.NUVZ4?@,%NW$IRIBL37*#8%/AA97C
MA[AA']&F,"DT..XCS(<=^<#KH7 I5V"]H--OWV!DU1(0-NSB8:+&Q61]2-BZ
ME@<7.#M(_LF!TAW./S&7%D,2O@*AX+H'!JX/Y]U#PZJL.&,NE843:W&[X0R<
MPWT [U=*V?>&.[:6_W48_P=02P,$%     @ (X$(69^@&_"Q @  X@P   T
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ".!"%D3^H+$200  ($0   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    "  C@0A9GZ ;\+$"  #B#   #0              @ &,#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( ".!"%F7BKL<P    !,"   +
M  "  6@/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ".!"%FJQ"(6,P$  "("
M   /              "  5$0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M"  C@0A9)!Z;HJT   #X 0  &@              @ &Q$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  C@0A999!YDAD!  #/ P
M$P              @ &6$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  #@$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cbus-20240808.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cibus.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cbus-20240808.htm">cbus-20240808.htm</File>
    <File>cbus-20240808.xsd</File>
    <File>cbus-20240808_lab.xml</File>
    <File>cbus-20240808_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cbus-20240808.htm": {
   "nsprefix": "cbus",
   "nsuri": "http://www.cibus.com/20240808",
   "dts": {
    "inline": {
     "local": [
      "cbus-20240808.htm"
     ]
    },
    "schema": {
     "local": [
      "cbus-20240808.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cbus-20240808_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cbus-20240808_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.cibus.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cbus-20240808.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cbus-20240808.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001628280-24-036131-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-036131-xbrl.zip
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MZWRCC4].U^^?/B<C$P>3#.N P0'1P&1GZ.J#M8$SC;_;,5+W0R5/4A(IDBQ
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MX%0SC:8.G^/_M7#"0 ?16!Q-_ #>9\M+6GK''.C=_D!=X80A5A?#8M?P9=/
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M=%<<ZQ-ZT5XCA/K/2#9_9"Z%*&>PRK3%\7S9B?>>9#\8&G7C?-<^P5634+L
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M9^^2$VFFM[ A##N.%F\1>_3NUR&.0JX:?9S[=^C;<_@QB:;NN_\%4$L#!!0
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MF.'E17SYY+\%T?^72./_4$L#!!0    ( ".!"%D($(5K: (  &<'   1
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ME:!$NV$XV@:'Q_:(HQA/(W^G2B_XJ[!C(<:5)IS"*;'-$QYX_R*'PYV>EL/
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MB7>!.TX.'@]TF^Y%^).#_P-02P$"% ,4    "  C@0A98A@1%A _  "D! ,
M%               @ $     8V)U<RTR,#(T,#8S,'AP<BYH=&U02P$"% ,4
M    "  C@0A91(390@0/  !:9P  $0              @ %"/P  8V)U<RTR
M,#(T,#@P."YH=&U02P$"% ,4    "  C@0A9"!"%:V@"  !G!P  $0
M        @ %U3@  8V)U<RTR,#(T,#@P."YX<V102P$"% ,4    "  C@0A9
M[@"]^@8*  !]5   %0              @ $,40  8V)U<RTR,#(T,#@P.%]L
M86(N>&UL4$L! A0#%     @ (X$(650[2F^O!@  V#   !4
M ( !15L  &-B=7,M,C R-# X,#A?<')E+GAM;%!+!08     !0 % $8!   G
%8@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>cbus-20240808_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cbus-20240808.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001705843</identifier>
        </entity>
        <period>
            <startDate>2024-08-08</startDate>
            <endDate>2024-08-08</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001705843</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-08-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Cibus, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38161</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">27-1967997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">6455 Nancy Ridge Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">450-0008</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Class A Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">CBUS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
